Ductal carcinoma in situ: Role of the boost;Radiothérapie des carcinomes canalaires in situ : impact du complément d'irradiation du lit tumoral

Cancer/Radiotherapie

Volumn 12, Issue 6-7, 2008, Pages 571-576

  Azria, D ^a,e   Auvray, H ^b,e   Barillot, I ^c,e   Baumann, P ^d,e   Benyoucef, A ^d,e   Bons Rosset, F ^e,f   Bontemps, P ^e,g   Bourgier, C ^e,h   Breton Callu, C ^e,i   Cowen, D ^e,j   Cretin, J ^e,k   Delalande, B ^e,l   Denis, F ^e,m   Ellis, S ^e,n   Gaci, Z ^e,o   Hannoun Levy J M ^e,p   Hasbini, A ^e,q   Hennequin, C ^e,r   Lagrange, J L ^e,s   Lartigau, E ^e,t   Latorzeff, I ^e,u   Le Blanc Onfroy, M ^e,v   Lecouillard, I ^e,w   Lemanski, C ^a,e   Levy, C ^e,x   Maingon, P ^e,y   Marchal, C ^e,z   Monnier, A ^e,aa   Pradier, O ^e,ab   Racadot, S ^e,ac   Romestaing, P ^e,ad   Serin, D ^e,ae   Simon, J M ^e,af   Teyssier, E ^e,ag   Tallet, A ^e,ah   Toledano A ^e,ai   Belkacemi Y ^e,s   more..

^a CENTRE VAL D AURELLE   (France)

^b CENTRE JEAN PERRIN   (France)

^c CHU BRETONNEAU   (France)

^d Centre d'Oncologie de Gentilly   (France)

^e CENTRE HENRI BECQUEREL   (France)

^f DEPARTMENT OF NEUROLOGY   (France)

^g UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ INSTITUT BERGONIÉ   (France)

^j TIMONE HOSPITAL   (France)

^k Clinique de Valdegour   (France)

^l CENTRE RENÉ HUGUENIN   (France)

^m CENTRE JEAN BERNARD   (France)

ⁿ Clinique Saint Pierre   (France)

^o Centre Catherine de Sienne   (France)

^p CENTRE ANTOINE LACASSAGNE   (France)

^q Clinique Armoricaine de Radiologie   (France)

^r SAINT LOUIS HOSPITAL   (France)

^s Section of Radiology   (France)

^t CENTRE OSCAR LAMBRET   (France)

^u Centre Oncorad Garonne   (France)

^v CENTRE RENÉ GAUDUCHEAU   (France)

^w CENTRE EUGÈNE MARQUIS   (France)

^x CENTRE FRANÇOIS BACLESSE   (France)

^y Centre G E Leclerc   (France)

^z CENTRE ALEXIS VAUTRIN   (France)

^aa Centre Hospitalier Belfort Montbéliard   (France)

^ab BREST UNIVERSITY HOSPITAL   (France)

^ac CENTRE LÉON BÉRARD   (France)

^ad CENTRE HOSPITALIER LYON SUD   (France)

^ae INSTITUT SAINTE CATHERINE   (France)

^af PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^ag Centre Azureen de Cancerologie   (France)

^ah INSTITUT PAOLI CALMETTES   (France)

^ai Clinique Hartmann   (France)

more..

Author keywords

Adjuvant; Boost; DCIS; Radiotherapy

Indexed keywords

BREAST CARCINOMA; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL EVALUATION; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DUCTAL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; SHORT SURVEY;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MULTICENTER STUDIES AS TOPIC; NECROSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 55849138988     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2008.07.005     Document Type: Short Survey

References (22)

1. Azria D., Gourgou S., Sozzi W.J., Zouhair A., Mirimanoff R.O., Kramar A., et al. Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer 91 (2004) 1251-1260
2. Azria D, Ozsahin M, Kramar A, Peters S, Atencio DP, Crompton NE, et al. Single nucleotide polymorphisms, apoptosis and the development of severe late adverse effects following radiotherapy. Clin Cancer Res; in press
3. Barillot I., Cututli B., and Arnould L. Ductal in situ carcinoma: is it ethical to consider the breast conserving therapy as a standard?. Cancer Radiother 8 (2004) 9-20
4. Bijker N., Meijnen P., Peterse J.L., Bogaerts J., Van Hoorebeeck I., Julien J.P., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European organisation for research and treatment of cancer randomized phase III trial 10853- a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24 (2006) 3381-3387
5. Bijker N., Peterse J.L., Duchateau L., Julien J.P., Fentiman I.S., Duval C., et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19 (2001) 2263-2271
6. Cutuli B., Cohen-Solal-le Nir C., de Lafontan B., Mignotte H., Fichet V., Fay R., et al. Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience. Int J Radiat Oncol Biol Phys 53 (2002) 868-879
7. Cutuli B., Fourquet A., Luporsi E., Arnould L., Caron Y., Cremoux P., et al. Standards Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004. Bull Cancer 92 (2005) 155-168
8. Emdin S.O., Granstrand B., Ringberg A., Sandelin K., Arnesson L.G., Nordgren H., et al. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol 45 (2006) 536-543
9. Ernster V.L., Barclay J., Kerlikowske K., Grady D., and Henderson C. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275 (1996) 913-918
10. Fisher B., Costantino J., Redmond C., Fisher E., Margolese R., Dimitrov N., et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328 (1993) 1581-1586
11. Fisher B., Dignam J., Wolmark N., Mamounas E., Costantino J., Poller W., et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16 (1998) 441-452
12. Fisher B., Digman J., Wolmark N., Wickerham D.L., Fisher E.R., Mamounas E., et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353 (1999) 1993-2000
13. Fisher B., Land S., Mamounas E., Dignam J., Fisher E.R., and Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 28 (2001) 400-418
14. Fisher E.R., Land S.R., Saad R.S., Fisher B., Wickerham D.L., Wang M., et al. Pathologic variables predictive of breast events in patients with ductal carcinoma in situ. Am J Clin Pathol 128 (2007) 86-91
15. Fourneret P., Artignan X., De Cornulier J., Pasquier P., Panh M.H., Payan R., et al. Analyse rétrospective de 108 carcinomes canalaires in situ mammaires traités par association radiochirurgicale. Cancer Radiother 10 (2006) 550-558
16. Ho A.Y., Atencio D.P., Peters S., Stock R.G., Formenti S.C., Cesaretti J.A., et al. Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. Int J Radiat Oncol Biol Phys 65 (2006) 646-655
17. Holmberg L., Garmo H., Granstrand B., Ringberg A., Arnesson L.G., Sandelin K., et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 26 (2008) 1247-1252
18. Houghton J., George W.D., Cuzick J., Duggan C., Fentiman I.S., and Spittle M. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362 (2003) 95-102
19. Julien J.P., Bijker N., Fentiman I.S., Peterse J.L., Delledonne V., Rouanet P., et al., EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet 355 (2000) 528-533
20. Omlin A., Amichetti M., Azria D., Cole B.F., Fourneret P., Poortmans P., et al. Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol 7 (2006) 652-656
21. Ozsahin M., Crompton N.E., Gourgou S., Kramar A., Li L., Shi Y., et al. CD4 and CD8 T-Lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res 11 (2005) 7426-7433
22. Solin L.J., Fourquet A., Vicini F.A., Haffty B., Taylor M., McCormick B., et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys 50 (2001) 991-1002